{
    "SPADE_N_01461": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 2008/0125359 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2008_0125359_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2008-5-29",
                "Family Info": "US7465784,US7985836,US20090156499,US20110251120",
                "Patent Title": "Antimicrobial peptides and methods of identifying the same.",
                "Abstract": "Antimicrobial peptides and methods of identifying the same are provided."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_01461",
            "Peptide Name": "Aurein-1.2 (Frogs, amphibians, animals)",
            "Source": "Litoria raniformis (Southern bell frog)",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GLFDIIKKIAESF",
            "Sequence Length": 13,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P82387"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer"
            ],
            "Target Organism": "Gram-positive bacteria:Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=50 μg/ml), Staphylococcus aureus (MIC=8 μmol/L);Gram-negative bacteria:Pasteurella multocida (MIC=100 μg/ml), Escherichia coli (MIC=8 μmol/L);Fungi:Candida albicans (MIC=32 μmol/L)",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Cell membrane",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C71H113N15O19",
            "Mass": 1480.75,
            "PI": 6.07,
            "Net Charge": 0,
            "Hydrophobicity": 0.67,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Probably acts by disturbing membrane functions with its amphipathic structure. Aurein 1.2 is HIV active (Wang G et al. 2010 Antimicrob. Agents Chemother. (54) 1343-1346). Aurein 1.2 is also the smallest amphibian peptide to show both antibiotic and Anti-cancer activity. The aurein antibiotics show more activity towards Gram-positive than Gram-negative pathogens. Expressed by the skin dorsal glands.",
            "Literature": [
                {
                    "Title": "The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.",
                    "Pubmed ID": "10951191",
                    "Reference": "Eur J Biochem. 2000 Sep;267(17)5330-5341.",
                    "Author": "Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=10951191"
                },
                {
                    "Title": "Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor.",
                    "Pubmed ID": "15572363",
                    "Reference": "J Biol Chem. 2005 Feb 18;280(7)5803-5811.",
                    "Author": "Wang G, Li Y, Li X.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15572363"
                },
                {
                    "Title": "Host-defence peptides of Australian anurans structure, mechanism of action and evolutionary significance.",
                    "Pubmed ID": "15203252",
                    "Reference": "Peptides. 2004 Jun;25(6)1035-1054.",
                    "Author": "Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15203252"
                }
            ],
            "Frequent Amino Acids": "IFK",
            "Absent Amino Acids": "CHMNOPQRTUVWY",
            "Basic Residues": 2,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 7,
            "Polar Residues": 4,
            "Positive Residues": 2,
            "Negative Residues": 2,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_05696",
                    "Similarity": 1.0,
                    "Sequence": "FSEAIKKIIDFLGEGLFDIIKKIAESF"
                },
                {
                    "SPADE_ID": "SPADE_N_05697",
                    "Similarity": 1.0,
                    "Sequence": "GLFDIIKKIAESFKFSEAIKKIIDFLG"
                },
                {
                    "SPADE_ID": "SPADE_UN_01707",
                    "Similarity": 1.0,
                    "Sequence": "GLFDIIKKIAES"
                }
            ]
        }
    }
}